RT @IsaacNunezs22: 'Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19' Inte…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 - ScienceDirect https://t.co/FuowHIdyPG
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @Dr_Cit: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
This is why the observational data should be taken seriously only after a properly designed and conducted RCT whether in #COVID19 or in any other situation... Thanks @drjohnm
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
Observational (single) case as well...
RT @keithsigelmd: An important new report on @IcahnMountSinai outcomes for #covid for anticoagulated patients by a nice guy @girish_nadkarn…
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
О важности применения антикоагулянтных и разжижающих кровь средств при коронавирусной инфекции. У тяжелобольных лиц с аппаратом ИВЛ – выживаемость здесь увеличилась с 37,3% до 70,9%. Ссылка - https://t.co/rWBtqAUovU Об этом на русском языке - https://t.co/
Complicada decisión. Sólo una estadística clara puede echar luz sobre esto.
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
COVID-19患者で人工呼吸管理になる患者の抗凝固療法はマストかなぁ。もちろんVV-ECMOでは、抗凝固療法は自動的に行っていたが。
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
'Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19' Interesante estudio observacional en @jaccjourn sobre covid-19 y anticoagulación 💉💉 1/11 https://t.co/mLiBfVMo0c
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at anticoagulation, an area of intense interest given propensity of Covid patients to clot. Both studies showed better outcomes for some p
RT @j_alvarezgarcia: 📣El uso de anticoagulación pdría relacionarse con mejor pronóstico en pacientes hospitalizados por #COVID19 👉Importan…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @jsenior64: Se debe utilizar la ciencia para beneficio de los pacientes. La anticoagulación tiene beneficios probados en pacientes con t…
RT @jsenior64: Encontraron la solución a la infección! Curvas de supervivencia espectaculares! Un momento, es una cohorte no un ensayo clín…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
Neither conservative nor good faith approach has adequate data support However conservative approach has history on its side
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
#Covid_19 can cause dangerous blood clots. In this new retrospective study by @MountSinaiNYC, anticoagulants (heparin etc.) seemed to halve the mortality (63% → 29%) among patients under mechanical ventilation, without a major increase in bleeding events.
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @MeedoTheLibyan: دراسة أعطي فيها 786 مريض كورونا مضادا للتخثر بينما 1987 مريضا اخر لم يعالجوا به. ولوحظ في النهاية إنخفاض معدل الوفيات خ…
RT @jungleland: So sad. A person who has COVID19 doesn’t need you to give them a brain bleed on top of it. #evidencebasedmedicine
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @mirvatalasnag: Important🧵 #OAC #COVID19 🔸Routine use of OAC @ study center, so control arm were those w contraindication (observational…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
دراسة أعطي فيها 786 مريض كورونا مضادا للتخثر بينما 1987 مريضا اخر لم يعالجوا به. ولوحظ في النهاية إنخفاض معدل الوفيات خاصة بين مرضى أجهزة التنفس الصناعي (بالانابيب عبر الفم) إلي 29.1% في المجموعة التي تلقت مضاد التخثر مقابل 62.7% في مجموعة المقارنة.
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
*Don't* go popping blood thinners (very hazardous w/o medical supervision). But this study is interesting b/c clots are an increasingly apparent complication of COVID19. Mortality for ventilated patients w/o anticoagulants: 63%. W/ anticoagulants: 29%. htt
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/96F01uIMTR, see more https://t.co/rZAoVHQvUa
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
#BigData News by @rvp Ravi VS Prasad - Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/mBSJswTcpj, see more https://t.co/f
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…